Viewing StudyNCT00503776



Ignite Creation Date: 2024-05-05 @ 6:33 PM
Last Modification Date: 2024-10-26 @ 9:34 AM
Study NCT ID: NCT00503776
Status: TERMINATED
Last Update Posted: 2017-06-20
First Post: 2007-07-17

Brief Title: ChemoXRT - Amifostine to Assess Outcomes Related to Xerostomia Mucositis Dysphagia
Sponsor: Vanderbilt-Ingram Cancer Center
Organization: Vanderbilt-Ingram Cancer Center

Conditions & Keywords Data

Conditions:
Name
Dysphagia
Head and Neck Cancer
Mucositis
Xerostomia
Keywords:
Name View
recurrent salivary gland cancer View
xerostomia View
mucositis View
dysphagia View
radiation toxicity View
chemotherapeutic agent toxicity View
stage III squamous cell carcinoma of the hypopharynx View
stage IV squamous cell carcinoma of the hypopharynx View
recurrent squamous cell carcinoma of the hypopharynx View
stage III squamous cell carcinoma of the larynx View
stage III verrucous carcinoma of the larynx View
stage IV squamous cell carcinoma of the larynx View
stage IV verrucous carcinoma of the larynx View
recurrent squamous cell carcinoma of the larynx View
recurrent verrucous carcinoma of the larynx View
stage III squamous cell carcinoma of the lip and oral cavity View
stage III verrucous carcinoma of the oral cavity View
stage IV squamous cell carcinoma of the lip and oral cavity View
stage IV verrucous carcinoma of the oral cavity View
recurrent squamous cell carcinoma of the lip and oral cavity View
recurrent verrucous carcinoma of the oral cavity View
stage III squamous cell carcinoma of the nasopharynx View
stage IV squamous cell carcinoma of the nasopharynx View
recurrent squamous cell carcinoma of the nasopharynx View
stage III squamous cell carcinoma of the oropharynx View
stage IV squamous cell carcinoma of the oropharynx View
recurrent squamous cell carcinoma of the oropharynx View
salivary gland squamous cell carcinoma View
stage III salivary gland cancer View
stage IV salivary gland cancer View